De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.
- DOI
- 10.1212/wnl.0000000000218482
- Published
- 2026 Sep 22
- Container
- Neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1212/wnl.0000000000218482,
title = {De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.},
author = {Hacohen Y and Androdias G and Arrambide G and Bruijstens AL and Ciccarelli O and Cobo-Calvo A and Flanagan EP and Kim HJ and Iacobaeus E and Lünemann JD and Stankoff B and Tintore M and Marignier R},
year = {2026},
journal = {Neurology},
doi = {10.1212/wnl.0000000000218482},
url = {https://doi.org/10.1212/wnl.0000000000218482}
}RIS
TY - JOUR TI - De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD. AU - Hacohen Y AU - Androdias G AU - Arrambide G AU - Bruijstens AL AU - Ciccarelli O AU - Cobo-Calvo A AU - Flanagan EP AU - Kim HJ AU - Iacobaeus E AU - Lünemann JD AU - Stankoff B AU - Tintore M AU - Marignier R PY - 2026 JO - Neurology DO - 10.1212/wnl.0000000000218482 UR - https://doi.org/10.1212/wnl.0000000000218482 ER -
APA
Y, H., G, A., G, A., AL, B., O, C., A, C., EP, F., HJ, K., E, I., JD, L., B, S., M, T., & R, M. (2026). De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.. Neurology. https://doi.org/10.1212/wnl.0000000000218482
Source records
- pubmed · retrieved 2026-09-26T20:52:33.858Z